Literature DB >> 28466405

Is it Always Necessary to Treat an Asymptomatic Hydronephrosis Due to Ureteropelvic Junction Obstruction?

Yogesh Kumar Sarin1.   

Abstract

The postnatal treatment of asymptomatic unilateral hydronephrosis due to ureteropelvic junction obstruction remains controversial, and the timing of and indications for surgical intervention are continuously debated. There is no consensus on the best follow-up during expectant management. The various modalities and parameters have been discussed along with their pros and cons and an attempt has been made to clear up the controversies.

Entities:  

Keywords:  Diuretic renography; Plasma renin activity; Pyeloplasty; Renal scintigraphy; Resistive index; Society for Fetal Urology grading; Ultrasonography; Unilateral hydronephrosis; Ureteropelvic junction obstruction; Urinary biomarkers

Mesh：

Year:  2017        PMID： 28466405     DOI： 10.1007/s12098-017-2346-9

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  52 in total

1.  Managing apparent ureteropelvic junction obstruction in the newborn.

Authors:  P C Cartwright; J W Duckett; M A Keating; H M Snyder; J Escala; B Blyth; S Heyman
Journal:  J Urol       Date:  1992-10       Impact factor: 7.450

2.  Diuresis renography for differentiation of upper urinary tract dilatation from obstruction: F+20 and F-15 methods.

Authors:  Rahim Taghavi; Kamran Ariana; Davoud Arab
Journal:  Urol J       Date:  2007       Impact factor: 1.510

3.  Prenatally diagnosed hydronephrosis: the Great Ormond Street experience.

Authors:  H K Dhillon
Journal:  Br J Urol       Date:  1998-04

4.  Pulsed Doppler sonography of the hilar renal artery: differentiation of obstructive from nonobstructive hydronephrosis in children.

Authors:  T Okada; H Yoshida; J Iwai; T Matsunaga; K Yoshino; Y Ohtsuka; K Kouchi; M Tanabe; N Ohnuma
Journal:  J Pediatr Surg       Date:  2001-03       Impact factor: 2.545

5.  Surgery versus observation for managing obstructive grade 3 to 4 unilateral hydronephrosis: a report from the Society for Fetal Urology.

Authors:  L S Palmer; M Maizels; P C Cartwright; S K Fernbach; J J Conway
Journal:  J Urol       Date:  1998-01       Impact factor: 7.450

6.  Guidelines for standard and diuretic renogram in children.

Authors:  Isky Gordon; Amy Piepsz; Rune Sixt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06       Impact factor: 9.236

7.  Antenatally detected pelvi-ureteric junction obstruction: concerns about conservative management.

Authors:  R Subramaniam; C Kouriefs; A P Dickson
Journal:  BJU Int       Date:  1999-08       Impact factor: 5.588

8.  Pressure flow measurement of hydronephrosis in children: a new approach to definition and quantification of obstruction.

Authors:  N Wåhlin; A Magnusson; A E Persson; G Läckgren; A Stenberg
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

9.  Observation of infants with SFU grades 3-4 hydronephrosis: worsening drainage with serial diuresis renography indicates surgical intervention and helps prevent loss of renal function.

Authors:  Sherry S Ross; Steve Kardos; Aaron Krill; Jason Bourland; Bruce Sprague; Massoud Majd; Hans G Pohl; M David Gibbons; A Barry Belman; H Gil Rushton
Journal:  J Pediatr Urol       Date:  2011-04-27       Impact factor: 1.830

10.  An alternative grading system to refine the criteria for severity of hydronephrosis and optimal treatment guidelines in neonates with primary UPJ-type hydronephrosis.

Authors:  Abdurrahman Onen
Journal:  J Pediatr Urol       Date:  2006-10-24       Impact factor: 1.830
View more
  2 in total

1.  Recent Advances and Controversies in Pediatric Surgery.

Authors:  Yogesh Kumar Sarin
Journal:  Indian J Pediatr       Date:  2017-06-14       Impact factor: 1.967

2.  Diuretic Enhanced Ultrasonography in the Diagnosis of Pyeloureteral Obstruction.

Authors:  Vytis Kazlauskas; Andrius Cekuolis; Vytautas Bilius; Marius Anglickis; Gilvydas Verkauskas
Journal:  Medicina (Kaunas)       Date:  2019-10-03       Impact factor: 2.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.